K Rössing, N Novak, S Mommert… - Clinical & …, 2011 - Wiley Online Library K. Rössing1, N. Novak2, S. Mommert1, F. Pfab3,4,5, M. Gehring1, B. Wedi1,4,5, A. Kapp1 and U. Raap1 1Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany, 2Department of Dermatology and Allergy, University of Bonn, Bonn, Germany, ... Related articles - All 2 versions
AB Zimmerman, EM Berger, SB Elmariah… - Journal of the American …, 2011 - Elsevier Improvement in urticaria was observed in 89% of patients, specifically 91% of patients with autoimmune urticaria and 88% with chronic idiopathic urticaria. Time to initial improvement ranged from 1 to 9 weeks. In 59% of these patients, complete control of urticaria was achieved, which ...
M Ferrer, P Gamboa, ML Sanz… - Journal of Allergy and …, 2011 - jacionline.org Disclosure of potential conflict of interest: AP Kaplan has served on advisory boards for Sanofi-Aventis and Novartis and on speakers' bureaus for Viro Pharma and Dyax. The rest of the authors have declared that they have no conflict of interest. Cited by 1 - Related articles - Cached - All 4 versions
M Maurer, S Altrichter, T Bieber… - The Journal of allergy …, 2011 - ncbi.nlm.nih.gov BACKGROUND: A subgroup of patients with chronic spontaneous urticaria (CU) exhibits IgE antibodies directed against autoantigens, such as thyroperoxidase (TPO). We conducted this study to investigate whether such patients with CU with IgE against TPO benefit from ... Cited by 1 - All 2 versions
I Baiardini, F Braido, C Bindslev‐Jensen… - Allergy, 2011 - Wiley Online Library 1Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy; 2Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark; 3University hospital, Department of Respiratory Medicine, Montpellier ... Related articles - All 3 versions